Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Merck
MRK
|
+$446M |
| 2 |
NVIDIA
NVDA
|
+$375M |
| 3 |
Apple
AAPL
|
+$319M |
| 4 |
EXE
Expand Energy Corporation Common Stock
EXE
|
+$317M |
| 5 |
Meta Platforms (Facebook)
META
|
+$310M |
Top Sells
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
Exxon Mobil
XOM
|
+$324M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
SoFi Technologies
SOFI
|
+$160M |
| 5 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
Sector Composition
| 1 | Technology | 20.48% |
| 2 | Financials | 18.31% |
| 3 | Industrials | 12.27% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Sensus Healthcare
SRTS
$52.6M
| $2.62M | ﹤0.01% |
378,568
+88,953
| +31% | +$616K |
|
2727
Duluth Holdings
DLTH
$132M
| $2.61M | ﹤0.01% |
843,672
+58,991
| +8% | +$182K |
|
|
ONL
2728
Orion Office REIT
ONL
$165M
| $2.59M | ﹤0.01% |
697,878
-14,516
| -2% | -$53.9K |
|
2729
NN Inc
NNBR
$121M
| $2.56M | ﹤0.01% |
783,033
+106,518
| +16% | +$348K |
|
2730
Bloom Energy
BE
$14.7B
| $2.54M | ﹤0.01% |
+114,352
| New | +$2.54M |
|
2731
Sana Biotechnology
SANA
$749M
| $2.54M | ﹤0.01% |
1,557,496
+478,596
| +44% | +$780K |
|
2732
Astria Therapeutics
ATXS
$423M
| $2.49M | ﹤0.01% |
278,072
-2,241
| -0.8% | -$20K |
|
|
SSBK
2733
DELISTED
Southern States Bancshares
SSBK
| $2.47M | ﹤0.01% |
74,176
+13,925
| +23% | +$464K |
|
|
VERV
2734
DELISTED
Verve Therapeutics
VERV
| $2.46M | ﹤0.01% |
437,089
+5,320
| +1% | +$30K |
|
2735
Viemed Healthcare
VMD
$256M
| $2.46M | ﹤0.01% |
306,522
| – | – |
|
2736
Keros Therapeutics
KROS
$636M
| $2.46M | ﹤0.01% |
155,163
+2,727
| +2% | +$43.2K |
|
2737
MeiraGTx Holdings
MGTX
$603M
| $2.43M | ﹤0.01% |
398,813
-51,081
| -11% | -$311K |
|
2738
Astera Labs
ALAB
$38.3B
| $2.42M | ﹤0.01% |
18,250
+768
| +4% | +$102K |
|
2739
RGC Resources
RGCO
$227M
| $2.42M | ﹤0.01% |
120,400
+3,684
| +3% | +$73.9K |
|
2740
Byrna Technologies
BYRN
$471M
| $2.41M | ﹤0.01% |
83,801
+45,730
| +120% | +$1.32M |
|
2741
ENI
E
$53B
| $2.41M | ﹤0.01% |
88,054
+11,824
| +16% | +$324K |
|
2742
Takeda Pharmaceutical
TAK
$48.3B
| $2.41M | ﹤0.01% |
181,929
+68,200
| +60% | +$903K |
|
2743
Rubrik
RBRK
$15.6B
| $2.4M | ﹤0.01% |
36,741
+1,363
| +4% | +$89.1K |
|
2744
Check Point Software Technologies
CHKP
$20.9B
| $2.37M | ﹤0.01% |
12,712
+103
| +0.8% | +$19.2K |
|
2745
Personalis
PSNL
$478M
| $2.37M | ﹤0.01% |
410,083
+242,141
| +144% | +$1.4M |
|
|
BHR
2746
Braemar Hotels & Resorts
BHR
$199M
| $2.35M | ﹤0.01% |
784,311
-27,576
| -3% | -$82.7K |
|
2747
Dyne Therapeutics
DYN
$1.89B
| $2.35M | ﹤0.01% |
99,578
-66,569
| -40% | -$1.57M |
|
|
DGICB
2748
Donegal Group Class B
DGICB
$617M
| $2.34M | ﹤0.01% |
165,787
| – | – |
|
2749
GrowGeneration
GRWG
$89.1M
| $2.33M | ﹤0.01% |
1,381,141
-50,561
| -4% | -$85.4K |
|
2750
MacroGenics
MGNX
$109M
| $2.33M | ﹤0.01% |
717,288
-165,372
| -19% | -$537K |
|